TARA

Protara Therapeutics Inc.

Price

$3.95

return (12m)

22.29%

p/e

-3.48

p/bv

1.51

DIVIDEND YIELD

0.00%

TARA price

Protara Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TARA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.23%

3 months

-5.05%

1 year

22.29%

2 years

105.73%

5 years

-49.62%

10 years

-98.92%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals TARA

Valuation

P/E

-3.48

Sector -4.23

Industry -4.23

P/BV

1.51

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

Sector -51.33

Industry -51.33

P/EBIT

Sector -39.56

Industry -39.56

P/Total Assets

1.38

Sector 1.25

Industry 1.25

P/Net Current Assets

1.85

Sector -5.36

Industry -5.36

P/Working Capital

1.83

Sector -1.24

Industry -1.24

EPS

-1.15

Sector -1.92

Industry -1.92

BVPS

2.64

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

0.00%

Sector 39.10%

Industry 39.10%

EBITDA Margin

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

0.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

0.00%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-43.41%

Sector -60.49%

Industry -60.49%

ROA

-39.76%

Sector -63.06%

Industry -63.06%

ROIC

0.00%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.97

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.92

Sector 0.43

Industry 0.43

Liabilities/Assets

0.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

8.18%

Sector -

Industry -

Fundamentals TARA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TARA Protara Therapeutics Inc.	$3.95	24.61%	0.00%	-3.48	1.51	-43.41%	0.00%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TARA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Protara Therapeutics

Protara Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

20 years

Founded: 2006

2020

Time since IPO - 6 years

29

Employees

Protara Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $243.39 million, with shareholders equity totaling $161.31 million.

The company employs approximately 29 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Protara Therapeutics Inc. reported $- in revenue, generating net income of $-70.02 million.

Key financial metrics include a P/E ratio of -3.48, a price-to-book (P/B) ratio of 1.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TARA.

Market cap

$243.39 million

Net worth

$161.31 million

$161,310,000.00

Assets

$176.09 million

$176,090,000.00

Total Shares Outstanding

61.00 million

61,000,000

Average Daily Trading Volume

$524.69 Thousand

$524,685.38

Sector

Health Care

Industry

Biotechnology

TARA

TARA revenue and profits

Financial Results TARA

DRAG THE FRAME TO SEE MORE DATA

TARA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Protara Therapeutics (TARA) today?

A cotação de Protara Therapeutics (TARA) hoje está em US$ 3.95, com uma variação de 22.29% em relação ao último ano. A cotação de Protara Therapeutics (TARA) iniciou o ano negociando na casa dos US$ 5.33 e hoje está em US$ 3.95. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Protara Therapeutics (TARA) e dados de ações do Ibovespa e mercados internacionais.

Quando Protara Therapeutics (TARA) paga dividendos?

Protara Therapeutics (TARA) não distribuiu dividendos no último ano.

Is Protara Therapeutics (TARA) a good investment?

Atualmente, Protara Therapeutics (TARA) está cotada a US$ 3.95, com um P/L de -3.48, representando um desvio de -237% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 22.29 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 22.29%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Protara Therapeutics (TARA) stock?

Investir em ações de Protara Therapeutics (TARA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Protara Therapeutics (TARA) yield today?

A rentabilidade de Protara Therapeutics (TARA) foi de -2.23% no último mês, 22.29% no último ano e -49.62% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Protara Therapeutics (TARA) hoje, o investimento total seria de US$ 395.00, com base na cotação atual de US$ 3.95.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 483.05
Em 5 anos: US$ 199.00
Em 10 anos: US$ 4.27

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TARA

Protara Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TARA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING TARA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Protara Therapeutics

Protara Therapeutics Inc.

United States

20 years

2020

29

PROFIT X PRICE TARA

Financial Results TARA

TARA cash flow

Asset, Revenue and Profit Growth - TARA

TARA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions